Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
75,954,164
-
Share change
-
+5,219,172
-
Total reported value
-
$1,117,203,308
-
Put/Call ratio
-
112%
-
Price per share
-
$14.71
-
Number of holders
-
128
-
Value change
-
+$78,589,190
-
Number of buys
-
89
-
Number of sells
-
51
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q4 2020
As of 31 Dec 2020,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,954,164 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., EVENTIDE ASSET MANAGEMENT, LLC, CITADEL ADVISORS LLC, VR Adviser, LLC, FRANKLIN RESOURCES INC, Avidity Partners Management LP, FRAZIER MANAGEMENT LLC, and ORBIMED ADVISORS LLC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.